This company listing is no longer active
Global Blood Therapeutics Management
Management Kriterienprüfungen 3/4
Wichtige Informationen
Ted Love
Geschäftsführender
US$8.2m
Gesamtvergütung
Prozentsatz des Geschäftsführergehalts | 8.7% |
Amtszeit als Geschäftsführer | 8.3yrs |
Eigentum des Geschäftsführers | 1.4% |
Durchschnittliche Amtszeit des Managements | 6.5yrs |
Durchschnittliche Amtszeit der Vorstandsmitglieder | 5.8yrs |
Jüngste Management Updates
Recent updates
Analyse der Geschäftsführervergütung
Datum | Gesamtvergütung | Gehalt | Unternehmensgewinne |
---|---|---|---|
Jun 30 2022 | n/a | n/a | -US$322m |
Mar 31 2022 | n/a | n/a | -US$310m |
Dec 31 2021 | US$8m | US$716k | -US$303m |
Sep 30 2021 | n/a | n/a | -US$277m |
Jun 30 2021 | n/a | n/a | -US$266m |
Mar 31 2021 | n/a | n/a | -US$249m |
Dec 31 2020 | US$18m | US$661k | -US$248m |
Sep 30 2020 | n/a | n/a | -US$282m |
Jun 30 2020 | n/a | n/a | -US$286m |
Mar 31 2020 | n/a | n/a | -US$291m |
Dec 31 2019 | US$10m | US$597k | -US$267m |
Sep 30 2019 | n/a | n/a | -US$220m |
Jun 30 2019 | n/a | n/a | -US$199m |
Mar 31 2019 | n/a | n/a | -US$182m |
Dec 31 2018 | US$10m | US$569k | -US$174m |
Sep 30 2018 | n/a | n/a | -US$166m |
Jun 30 2018 | n/a | n/a | -US$152m |
Mar 31 2018 | n/a | n/a | -US$135m |
Dec 31 2017 | US$8m | US$520k | -US$117m |
Sep 30 2017 | n/a | n/a | -US$103m |
Jun 30 2017 | n/a | n/a | -US$95m |
Mar 31 2017 | n/a | n/a | -US$89m |
Dec 31 2016 | US$1m | US$479k | -US$82m |
Sep 30 2016 | n/a | n/a | -US$71m |
Jun 30 2016 | n/a | n/a | -US$65m |
Mar 31 2016 | n/a | n/a | -US$58m |
Dec 31 2015 | US$2m | US$438k | -US$51m |
Vergütung im Vergleich zum Markt: Ted's total compensation ($USD8.19M) is above average for companies of similar size in the UK market ($USD2.71M).
Entschädigung vs. Einkommen: Ted's compensation has been consistent with company performance over the past year.
Geschäftsführer
Ted Love (63 yo)
8.3yrs
Amtszeit
US$8,193,309
Vergütung
Dr. Ted W. Love, M.D., serves as Independent Director at Royalty Pharma plc since July 30, 2020. He serves as Director of Seagen Inc. (formerly known as Seattle Genetics, Inc.). since August 2020. He serve...
Führungsteam
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
President | 8.3yrs | US$8.19m | 1.37% $ 63.2m | |
CFO & Principal Accounting Officer | 6.5yrs | US$2.76m | 0.040% $ 1.8m | |
Chief Business & Strategy Officer | 7.5yrs | US$2.73m | 0.37% $ 17.2m | |
Chief Commercial Officer | 4.6yrs | US$2.75m | 0.084% $ 3.9m | |
Executive VP and Head of Research & Development | 1.4yrs | US$2.98m | 0.0089% $ 409.5k | |
Founder & Advisor | 11.8yrs | keine Daten | keine Daten | |
Founder & Advisor | 11.8yrs | keine Daten | keine Daten | |
Founder & Advisor | 11.8yrs | keine Daten | keine Daten | |
Executive Vice President of Operations | 2.5yrs | keine Daten | 0.062% $ 2.9m | |
Senior Director of Corporate Communications & Investor Relations | no data | keine Daten | keine Daten | |
Chief Legal Officer & Secretary | 6yrs | US$5.93m | 0.064% $ 3.0m | |
Senior VP & Head of Corporate Communications | 3.8yrs | keine Daten | keine Daten |
6.5yrs
Durchschnittliche Betriebszugehörigkeit
60yo
Durchschnittliches Alter
Erfahrenes Management: 0IVZ's management team is seasoned and experienced (6.5 years average tenure).
Vorstandsmitglieder
Name | Position | Amtszeit | Vergütung | Eigentümerschaft |
---|---|---|---|---|
President | 9.1yrs | US$8.19m | 1.37% $ 63.2m | |
Lead Independent Director | 7.5yrs | US$348.28k | 0.056% $ 2.6m | |
Independent Director | 4.8yrs | US$320.78k | 0.017% $ 783.3k | |
Independent Director | 2.4yrs | US$313.28k | 0.013% $ 618.8k | |
Independent Director | 6.7yrs | US$318.28k | 0.039% $ 1.8m | |
Independent Director | 7.1yrs | US$310.78k | 0.013% $ 623.9k | |
Independent Director | 6.8yrs | US$333.28k | 0.0098% $ 454.8k | |
Independent Director | 3.8yrs | US$316.36k | 0.0080% $ 368.3k | |
Advisor & Director Emeritus | less than a year | US$308.28k | 0.058% $ 2.7m | |
Independent Director | 1.6yrs | US$735.61k | 0.0049% $ 226.5k |
5.8yrs
Durchschnittliche Betriebszugehörigkeit
66yo
Durchschnittliches Alter
Erfahrener Vorstand: 0IVZ's board of directors are considered experienced (5.8 years average tenure).